Mariana de Souza Alves
Research Subjects
Research Interests
Mariana de Souza Alves has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Andreia Cristina Dalbello Rissati
Campinas Oncology Center, Campinas, São Paulo, Brazil
1 shared publication - Fernando Medina da Cunha
Campinas Oncology Center, Campinas, São Paulo, Brazil
1 shared publication - Tiago Merlo
Campinas Oncology Center, Campinas, São Paulo, Brazil
1 shared publication
Latest Publications
- Open Access
- 24 September 2026
- Published by Zotarelli-Filho Scientific Works in International Journal of Nutrology
- Vol. 19 (4)
Use of an oral rehydration solution to prevent and treat dehydration during chemotherapy: a case series
Introduction: Oral rehydration solutions (ORS) have been widely used for fluid replacement in clinical settings. Some studies have considered oral rehydration an alternative to intravenous hydration to prevent chemotherapy-induced nephrotoxicity. Objectives: This study aimed to evaluate the feasibility, acceptability, and efficacy of a ready-to-use ORS for hydrating cancer patients before chemotherapy. Methods: Eight chemotherapy patients at risk of dehydration were selected. Patients received ready-to-use ORS for three days before chemotherapy and were evaluated before and after chemotherapy over 4 cycles of treatment. Results: One patient died before the final evaluation. At baseline, none of the patients had either suitable hydration level or normal diuresis; 7 of them showed dehydrated mucous membranes. After the hydration protocol, 5 patients had suitable hydration level; urine concentration was normal in 6 patients; mucous membranes were hydrated in all 7 patients. Previous studies have shown the effectiveness and usefulness of oral rehydration after chemotherapy. The present study showed that administration of ready-to-use ORS before chemotherapy improved hydration levels. Conclusion: Ready-to-use oral rehydration solution can be used for hydration of cancer patients, with advantages in terms of convenience, acceptability, safety, and time. Studies with more patients may lead to definitive conclusions on its use in these conditions.
- 24 September 2026
- Published by Zotarelli-Filho Scientific Works in International Journal of Nutrology
- Vol. 19 (4)
Open AccessUse of an oral rehydration solution to prevent and treat dehydration during chemotherapy: a case series
Introduction: Oral rehydration solutions (ORS) have been widely used for fluid replacement in clinical settings. Some studies have considered oral rehydration an alternative to intravenous hydration to prevent chemotherapy-induced nephrotoxicity. Objectives: This study aimed to evaluate the feasibility, acceptability, and efficacy of a ready-to-use ORS for hydrating cancer patients before chemotherapy. Methods: Eight chemotherapy patients at risk of dehydration were selected. Patients received ready-to-use ORS for three days before chemotherapy and were evaluated before and after chemotherapy over 4 cycles of treatment. Results: One patient died before the final evaluation. At baseline, none of the patients had either suitable hydration level or normal diuresis; 7 of them showed dehydrated mucous membranes. After the hydration protocol, 5 patients had suitable hydration level; urine concentration was normal in 6 patients; mucous membranes were hydrated in all 7 patients. Previous studies have shown the effectiveness and usefulness of oral rehydration after chemotherapy. The present study showed that administration of ready-to-use ORS before chemotherapy improved hydration levels. Conclusion: Ready-to-use oral rehydration solution can be used for hydration of cancer patients, with advantages in terms of convenience, acceptability, safety, and time. Studies with more patients may lead to definitive conclusions on its use in these conditions.